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j Abstract Background The im-
pact of attention deficit hyperac-
tive disorder (ADHD) in the
Netherlands on health care util-
isation, costs and quality of life of
these children, as well as of their
parents is unknown. Objective
The aim of this study was to assess
the direct medical costs of patients
suffering from ADHD and their
quality of life as well as the direct
medical costs of their mothers.
Study design We selected a group
of 70 children who were being
treated by a paediatrician for
ADHD based on the DSM-IV
diagnostic criteria for ADHD. For
comparison’s sake, we also in-
cluded a non-matched group of 35
children with behaviour problems
and 60 children with no behaviour
problem from a large school pop-
ulation-based study on the detec-
tion of ADHD. We collected
information on the health care
utilisation of the children applying
the Trimbos and iMTA question-
naire on Costs associated with
Psychiatric illness’ (TiC-P). Their
health related quality of life was
collected by using the Dutch 50-
item parent version of the Child
Health Questionnaire (CHQ PF-
50). Measurements were at base-
line and at 6 months. Subse-
quently, we collected data on the
health utilisation of the mothers
and their production losses due to
absence from work and reduced
efficiency. Results The mean di-
rect medical costs per ADHD
patient per year were e2040 or
e1173 when leaving out one
patient with a long-term hospital
admission, compared to e288 for
the group of children with behav-
iour problems and e177 for the
group of children with no behav-
iour problems. The direct medical
costs for children who had psy-
chiatric co-morbidities were sig-
nificantly higher compared to
children with ADHD alone. The
mean medical costs per year for
the mothers of the ADHD patients
were significantly higher than for
the mothers of the children with
behaviour problems and the
mothers of children with no
behaviour problems respectively
e728, e202 and e154. The phys-
ical summary score showed no
significant differences between the
groups. However, the score on the
Psychosocial Summary Score
dimension was significantly lower
for ADHD patients compared to
the scores of the children in the
two other samples. The mean
annual indirect costs due to
absence from work and reduced
efficiency at work were e2243 for
the mothers of the ADHD patients
compared to e408 for the mothers
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Introduction
Attention deficit hyperactivity disorder (ADHD) is
characterised by a persistent pattern of overactivity,
inattention and impulsivity that is pervasive across
situations and accompanied by substantial impair-
ments in family and social relationships [1]. ADHD is
a relatively common disorder that occurs in 8% of the
children between five and fourteen years old [6]. The
prevalence rate among boys is higher than for girls
[22]. Typical symptoms of children suffering from
ADHD are failing to remain seated, talking exces-
sively, playing noisily, and blurting out answers be-
fore the questions have been completed [1]. The
symptoms of ADHD may interfere with a person’s
ability to conduct normal daily activities. ADHD is
associated with broad impairment in many Health
Related Quality of Life (HRQoL) parameters, includ-
ing academic performance, behaviour at school, peer
relations and family function [5]. Studies have indi-
cated that, compared to their peers without ADHD,
young people with ADHD also exhibit higher levels of
comorbidity with other psychiatric disorders as
oppositional defiant disorder, conduct disorder, anx-
iety disorder and depression, and with somatic con-
ditions as asthma [2]. Furthermore, they have an
increased risk of accidents and severe injury [2].
ADHD may also affect the health and ability to work
of family members [2]. The coexisting psychiatric
conditions may add to the impairment associated
with ADHD, as well as to the disorder’s economic
burden.
Because of the broad impact of ADHD, the disor-
der is likely to have significant economic implications
for society and for the quality of life of patients and
their family. Studies have shown that subjects with
ADHD have a substantially greater use of care, next to
an impaired quality of life [7, 15]. A recent paper by
Matza, reviewing and summarizing the growing body
of literature on the economic burden of ADHD pri-
marily published in the United States [8] clearly
showed that ADHD places a substantial economic
burden on patients, families and third-party players
[8]. Results of medical costs studies showed that
children with ADHD had higher annual medical costs
than either matched controls (difference ranged from
$503 to $1343) or non-matched controls (difference
range from $207 to $1560) without ADHD [8]. A
limited number of studies have examined other eco-
nomic implications of ADHD, such as the cost to
families, indirect costs associated with work loss
among parents of children suffering from ADHD [16,
25, 26].
A number of studies have also indicated that the
impact of ADHD on HRQoL is significant [11, 19, 27].
Escobar et al. showed that ADHD interferes to an
even greater extent than asthma with the daily lives of
children, parents and families, primarily in areas re-
lated to psychosocial functioning [5].
The impact of the disorder in the Netherlands on
health care utilisation, costs and quality of life of these
children, as well as of their parents is unknown.
Hence, the aim of this study was to estimate the direct
costs incurred for the medical care of patients with
ADHD. Furthermore, we assessed the HRQoL of these
patients by using the Child Health Questionnaire [13,
27]. Additionally, we estimated the direct medical
costs for care provided to their mothers and the
indirect costs due to absenteeism, reduced efficiency
at work and impediments due to behaviour problems
of their child. We compared these results with esti-
mates for a group of children with behaviour prob-
lems and with a group of non-matched controls.
Additionally, we compared the costs and quality of
life scores within the group of ADHD patients with
and without psychiatric comorbidity.
Methods
j Study sample
For this study, we selected a group of 70 children who
were being treated by a paediatrician for ADHD.
ADHD patients were diagnosed by a multidisciplinary
team of medical doctors, children’s psychologist and
an orthopedagogue. The diagnosis was based on the
DSM-IV diagnostic criteria for ADHD. This group will
of children with behaviour prob-
lems and e674 for the mothers of
children with no behaviour prob-
lems. Conclusion Our study
showed that the direct medical
costs of ADHD patients were rel-
atively high. Additionally, our
study indicated that ADHD ap-
pears to be accompanied by higher
(mental) health care costs for the
mothers of ADHD patients and by
increased indirect costs for this
group.
j Key words ADHD –
societal costs – quality of life
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be referred to as ADHD patients’ throughout the
paper. For comparison’s sake, we also recruited two
groups of children from a study on the detection of
ADHD among children of different ethnic origin in
the Netherlands (ADEON) [28]. The aim of the
ADEON project was to develop and validate a tool
(diagnostic score) that could be used as a rapid initial
assessment of the probability of ADHD in non-re-
ferred school age children, taking ethnicity into ac-
count. Initially, teachers in Amsterdam and Utrecht
were asked to rate a population of 3,000 six to seven
year-olds, made up of the pupils in their classes, on a
rating scale. Some 300 children (150 with low scores
and 150 with high scores for externalizing items) were
subsequently invited for detailed assessments. We
selected a group of 60 children from the ADEON
study population with low scores, i.e. no behaviour
problems, and 35 children with behaviour problems,
i.e. with scores in the 90th percentile and higher. Of
the latter group, a total of 12 children were eventually
diagnosed with ADHD by a psychiatrist, based on the
DSM-IV diagnostic criteria for ADHD.
Unfortunately, we could not match the three
groups by age and sex, as the group of ADHD patients
being treated by a paediatrician was relatively old and
contained relatively more boys than the group of six
to seven year-olds recruited from the ADEON study.
In the paper, the group of children with low scores
will be referred to as children with no behaviour
problems’ and the group with high scores as children
with behaviour problems’.
j Measures and data analyses
Our study was conducted from a societal perspective
and included assessments of quality of life, direct
medical and direct medical- and indirect costs of the
mothers. Information on the health care utilisation of
the children and their health related quality of life
were collected using questionnaires, which were sent
to the home address of the participants. Enrolment
commenced in November 2002 and stopped in Feb-
ruary 2004; follow-up data were collected until August
2004. For all groups measurements were at baseline
and at 6 months using a postal questionnaire. The
recall period was 3 months; we assumed this period to
be representative for the 6-month period. Subse-
quently, we collected data on the health utilisation of
the mothers and their production losses due to ab-
sence from work and reduced efficiency. In cases
where the mother was unable to fill out the ques-
tionnaire, we asked another person to do so. These
subjects were also asked to indicate their relationship
to the child. For the purpose of brevity, the term
mother’ should be assumed to include both the
mothers and the small group of respondents with
some other relationship to the child.
The collected data included socio-demographic
characteristics of the children and their mothers, such
as sex, age, educational level of the children, and the
work status of the mother at baseline. For the group of
ADHD patients, we collected data on psychiatric
comorbidity from the patient files. Comorbidity was
defined as the presence of any additional or co-
existing psychiatric disorder stated in the relevant
patient’s file. Also, we compared the baseline scores
with the scores at six months after of incident patients
were included in the ADHD sample. An incident case
was defined as a respondent whose first contact with
the paediatrician occurred on the date of inclusion,
e.g., at the baseline measurement. Where data from
the second measurement, i.e., at six months, were
missing, we applied linear extrapolation (LE).
Applying LE, the direct medical costs and indirect
costs due to absenteeism and reduced efficiency at
work were extrapolated to one year by multiplying the
costs of first six months by two.
j Direct and indirect costs
Direct costs were defined as the monetary valuation of
the resources used to detect and treat medical prob-
lems. The indirect costs were defined as the produc-
tivity lost due to absenteeism and reduced efficiency
at work.
For all groups we used the Trimbos and iMTA
questionnaire on Costs associated with Psychiatric
illness’ (TiC-P) to collect data on direct and indirect
costs [8]. The first part of the TiC-P consists of ques-
tions on the number of contacts with health care
providers, including the general practitioner (GP),
psychiatrist, medical specialists, speech therapist,
(psychiatric) day care/hospital length of stay, medi-
cation and out-of-pocket costs. Bottom-up method-
ology was used to calculate the total direct medical
costs; that is, the total number of medical contacts
(outpatient visits, hospital length of stay, use of
medication, etc.) was multiplied by the 2004 reference
unit prices of the corresponding health care service
[21]. In this way, we assessed the overall direct medical
costs of this group of patients suffering from ADHD.
Next, we assessed health-related school absentee-
ism and failure to participate in sports, without,
however, assigning a monetary value to these items.
The recall period for the TiC-P was three months. In
estimating the costs over the period of half a year, we
assumed that the costs per three months could be
taken as representative of the preceding six months.
The annual costs were calculated by adding up the
costs per half year.
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In parallel, the mothers were asked to fill out the
TiC-P with regard to their own health care utilisation.
The TiC-P for mothers also included a short form of
the Health and Labour questionnaire (HLQ) for col-
lecting data on productivity losses [24]. The Short-
Form HLQ (SF-HLQ) consists of three modules that
measure productivity losses: absence from work, re-
duced efficiency at work, and difficulties with job
performance [3]. The days of absence from work and
actual cost of hours missed at work due to health-
related problems were valued by the net income per
day and per hour, respectively. The friction-cost
method was applied to assess the productivity losses
[12]. This method takes into account the economic
circumstances that limit the losses of productivity to
society, which is related to the fact that a formerly
unemployed person may replace a person who be-
comes disabled [12]. The period needed to replace a
worker (the so-called friction period) is estimated to
be 154 days. The number of lost working days per
respondent was calculated taking into account the
number days and hours of paid employment per week.
To collect data on reduced efficiency at work,
respondents with paid jobs were asked to estimate the
number of extra hours they would have had to have
worked to compensate for the health-related work
productivity loss incurred. We estimated an impedi-
ment score to assess the amount of difficulty experi-
enced in performing both paid and unpaid jobs.
Unpaid jobs were defined as household work, shop-
ping, childcare (in this context, taking care of one’s
own children), and odd jobs around the house.
Individuals with paid jobs were asked to indicate
the degree of impediment they experienced while
performing their paid jobs. The response categories
were: 0 = no impediment’, 1 = some impediment’,
and 2 = a lot of impediment’. The impediment score
for a paid job ranged from 0 to 2.
Moreover, a descriptive instrument comprising
seven items was used to evaluate underlying problems
causing reduced efficiency while performing a paid
job, and to calculate the efficiency score. The items
were concentration, working pace, need to be alone,
decision making, postponement of work, taking over
work by others and other (the latter was an open-end
question). Response modalities were 1 = never’,
2 = sometimes’, 3 = often’, and 4 = always’. The
efficiency score for a paid job was calculated by
adding up the scores for the first six items and ranged
from 6 to 24.
For each category of a unpaid work (household
work, shopping, childcare, odd jobs around the
house), the response categories and scores were
comparable with those for a paid job: 0 = no
impediment’, 1 = some impediment’ and 2 = a lot of
impediment’. The impediment score for unpaid work
was calculated by adding up the scores for four cat-
egories of unpaid work; the scores ranged from 0 to 8.
j Quality of life
The quality of life of the children was assessed by
using the Dutch 50-item parent version of the CHQ
[27]. The CHQ-PF50 is a generic health status
instrument designed to measure the physical and
psychosocial well being of children aged five and
older. The CHQ-PF50 assesses children’s physical and
mental health and the parent’s perception of the ex-
tent to which problems in these areas interfere with
peer and school activities, family activities, and the
lives of the parents. It has been applied in general
populations and as well in studies with chronically ill
children in several countries [14]. The CHQ-PF50
includes a broad spectrum of child and family focused
health areas, broken down into: physical functioning,
role/social limitations-emotional/behavioural, role /
social limitations physical, bodily pain/discomfort,
behaviour, mental health, self-esteem, general health
perceptions parent impact-emotional, parent impact
time, family activities and family cohesion. Most
items require parents to respond using a four week
recall period, and items are rated on 4-point, 5-point,
and 6-point Likert scales. Two summary scores, the
Psychosocial Summary Scale and the Physical Sum-
mary Scale, were derived for the weighted combina-
tions of the domain subscale scores. The summary
scores were transformed to achieve a score range of
0–100, with higher scores representing a better
HRQoL. The CHQ-PF50 has been tested and validated
with normative values developed for ADHD, asthma,
cystic fibrosis, epilepsy and juvenile rheumatoid
arthritis for the US population [14].
j Data analysis and statistics
Statistical analysis was performed using the SPSS
statistical software (version 13.0; SPPS Inc., Chicago,
IL, USA). We applied non parametric tests to assess
differences between groups and differences in base-




The response rate of the group of ADHD children
treated by a paediatrician was 92% (n = 65). For the
group of children with behaviour problems, the re-
sponse rate was 94% (n = 33), including 12 respon-
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dents diagnosed with ADHD according to the stan-
dard DSM-IV criteria. The response rate for the group
of children with no behaviour problems was relatively
low, 78% (n = 47).
Table 1 presents the general characteristics at
baseline of all the respondents in the three groups.
The mean age of the patients in the ADHD group was
higher than that of the two other groups, as was the
number of boys in this group. Fourteen (22%) ADHD
patients were found to have a co-morbid psychiatric
diagnosis; only one patient, however, had more than
one co-morbid psychiatric condition. The co-mor-
bidities reported included oppositional defiant dis-
order (ODD), anxiety disorder, pervasive
development disorder (PDD) and other psychiatric
not otherwise specified disorders. Fifty-one percent
(n = 33) of the ADHD patients visited the paediatri-
cian for the first time at baseline and were treated as
incidence cases in the analyses.
Fifteen percent of the ADHD patients were in spe-
cial education, compared to none in the other study
groups. Nearly half of the ADHD patients had missed
one or more days of school during the three months
preceding the interview. At six months, the response
rate was 89% (n = 58), 79% (n = 26), and 91%
(n = 43) for the ADHD patients, the group of children
with behaviour problems and children with no
behaviour problems, respectively. There were no be-
tween-group differences in missing service use data.
j Direct costs
Table 2 presents the mean annual direct medical costs
incurred by the ADHD patients and their mothers.
These costs are broken down by type of medical
service and the percentage of respondents using a
particular medical service. The mean direct medical
costs per child per year were over e2000, compared to
e288 for the group of children with behaviour
problems and e177 for the comparison group.
The cost of hospital stays accounted for over one
third of the annual costs for the ADHD patient
group; the brunt of these costs were, however, borne
by a single patient’s 84-day admission to a psychi-
atric hospital. If this patient is left out of the anal-
ysis, the mean direct medical costs fall to e1173.
This reflects the substantial impact of a long stay
admission to hospital. Ambulatory mental health
care accounted for a quarter of the mean direct
costs, as shown in Table 2. The paediatrician was the
most commonly consulted health service. However,
this was to be expected, as the group of children
with ADHD was selected from a population being
treated by a paediatrician for ADHD. Three quarters
of the children diagnosed with ADHD were on
medication, which accounted for 13% of the direct
medical costs. The out-of-pocket costs per year for
children with ADHD were on average nearly e20(SD
e130). Children of both other groups did not have
out-of-pocket costs.
The mean direct medical costs per year for chil-
dren who had psychiatric co-morbidities were e5908,
compared to only e974 for children with ADHD
alone. If the child who was admitted to hospital is left
out, the mean costs of the group of patients with
comorbidity would be reduced to e1946.
The mean medical costs per year for the mothers of
the ADHD patients were over e700, as shown in Ta-
ble 2. The total mean annual direct medical costs for
Table 1 General characteristics of the three study groups, children with ADHD (DSM-IV) treated by a pediatrician, children with behaviour problems and children








Average age child, years; Mean (SD) 10.5 (2.7) 9.3 (1.0) 7.8 (1.0)
Men child; N (%) 52 (80%) 17 (52%) 17 (36%)
Comorbidity child; N (%)
Oppositional defiant disorder 5 (8%) na na
Anxiety disorder 1 (2%) na na
Pervasive development disorder 6 (9%) na na
Other psychiatric not specified disorders 3 (5%) na na
Type of school; N (%)
Elementary school 43 (66%) 33 (100%) 47 (100%)
Secondary school 12 (18%) 0 (0%) 0 (0%)
Special education 10 (15%) 0 (0%) 0 (0%)
Average age mother, years; Mean (SD) 38.6 (4.6) 37.5 (7.7) 38.0 (5.4)
Mothers* with paid work; N (%) 50 (77%) 18 (55%) 27 (57%)
ADHD = attention-deficit hyperactivity disorder
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the mothers of the children with behaviour problems
were e202, and for the mothers of the children with
no behaviour problems, e154.
For the mothers of the ADHD patients, visits to
the ambulatory mental health care service accounted
for over half of the mean direct medical costs per
year. As a group, these mothers made significantly
more use of and incurred significantly higher costs
for mental health care, including the costs of
ambulatory mental health care, psychiatric practice
and outpatient psychiatric care, than did the moth-
ers of the group of children with behaviour problems
and of the mothers of the children with no behav-
iour problems, respectively e541, e47 and e35.
Furthermore, 4 out of 10 mothers of the ADHD
patients had consulted the general practitioner and
slightly over 40% of the mothers were using psy-
chotropic medications. Overall, a quarter of the
mothers of the ADHD patients indicated that they
had used health care services for themselves for
reasons related to the behaviour problems of their
child.
The annual mean direct medical costs for mothers
of the ADHD patients with psychiatric comorbidity
were e839, compared to mean direct medical costs of
e755 for mothers of children with ADHD only
j Indirect costs
Absence from work
About three quarters of the mothers of the ADHD
patients had a paid job (see Table 1). This percentage
was higher than that of the mothers in the two other
groups (Table 1). Table 3 shows the indirect cost data
for mothers with a paid job. For the group of mothers
of the ADHD patients, 16% were absent from work
due to health-related problems. The mean number of
days absent from work per year was over 17 days.
Generally, the period of absenteeism was relatively
short; only one mother indicated she had been absent
for a period of longer than two weeks. The mean
indirect costs per year due to absence from work were
e1691 per mother. By comparison, the mean annual
number of missed days at work was nearly three days
for the mothers of the children with behaviour
problems, with corresponding mean annual costs of
Table 2 Mean direct medical cost per year for children with ADHD and their mothersa (in euros)










General practitioner 33 (18) 2 19 (29)
Ambulatory mental health care 501 (416) 25 21 (32)
Psychiatric practice 79 (71) 4 14 (22)
Out-patient psychiatrist 52 (90) 3 9 (14)
School doctor 25 (22) 1 8 (12)
Paediatrician 144 (26) 7 55 (85)
Medical specialist 26 (21) 1 7 (11)
Physiotherapist 30 (35) 1 3 (5)
Speech therapist 75 (88) 4 6 (9)
Social worker 60 (91) 3 5 (8)
Alternative health practitioner 32 (64) 2 4 (6)
Hospital days 723 (2676) 35 1 (2)
Medication 260 (59) 13 48 (75)
Total 2,040 (943) 100
Mothersa
General practitioner 54 (27) 7 26 (40)
Ambulatory mental health care 412 (386) 57 19 (30)
Psychiatric practice 74 (82) 10 7 (11)
Out-patient psychiatrist 55 (89) 8 6 (9)
Company doctor 11 (19) 2 6 (9)
Social worker 57 (59) 8 8 (12)
Consultant alcohol & drugs 2 (7) 0 1 (2)
Alternative health practitioner 28 (39) 4 3 (5)
Medication 35 (14) 5 28 (43)
Total 728 (432) 100
aIn this study this group consisted of 82% mothers, 17% fathers, and 1% others, referred to as mothers’
ADHD = attention-deficit hyperactivity disorder
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e408, and six days for the screen negatives with the
corresponding mean annual costs of e674.
j Reduced efficiency at work
The mean productivity losses due to reduced effi-
ciency at work were approximately five days per year
for the mothers of the ADHD patients (Table 3). The
mean annual associated costs were nearly e552. Of
the group of mothers with a child with behaviour
problems, only one mother indicated that she had
experienced health-related productivity loss due to
reduced efficiency. The mean number of days lost due
to reduced efficiency was therefore low, about half a
working day per year. The group of mothers of the
screen negatives reported no production losses due to
reduced efficiency.
j Difficulties with job performance
A third of the mothers of the ADHD patients with a
paid job experienced difficulties at work because of
health-related problems at baseline. The impediment
score associated with paid jobs was 0.38 for mothers
of the ADHD patients. This score was significantly
higher than the 0.18 found for mothers of children
with behaviour problems and the 0.15 scored by the
screen negative sample, indicating that mothers of
ADHD patients indeed experience more difficulties.
Approximately one third (36%) of the mothers of the
ADHD patients indicated they needed to be alone.
Approximately one fifth occasionally experienced
problems with concentration, working pace and
decision making. Only 6% of the mothers of the
ADHD patients reported having to postpone work.
The resulting efficiency score was 13.0 for the mothers
of the ADHD patients versus 6.31 for the mothers of
children with behaviour problems and 6.44 for the
mothers of the children with no behaviour problems.
This suggests that mothers of ADHD patients indeed
experience more problems in performing their jobs.
Twenty percent of the mothers of the ADHD pa-
tients indicated that they experienced problems in
performing unpaid work, e.g., household work. Over
12 percent of the mothers reported difficulties in
taking care of their child(ren). The mean impediment
score for unpaid work in the group of mothers of the
ADHD patients was higher than for the mothers of the
children with no behaviour problems and children
with behaviour problems. However, the difference
between the samples was not significant: 0.67 versus
0.47 and 0.43 respectively.
j Quality of life
Table 4 presents the mean scores of these measure-
ments for the different items of the CHQ-PF50 and the
summary scores in the three groups at baseline. The
physical summary score (PhS) showed no significant
differences between the groups. However, the score
on the Psychosocial Summary Score (PsS) dimension
was significantly lower for ADHD patients compared
to the scores of the children in the two other samples.
Additionally, the global parent’s rating of the present
health of the child (GGH) and scores on general
health (GH) were significantly lower in the ADHD
patients. This dimension represents the parents’ per-
ception of the health of their children in general and
expectations regarding the health of their children in
the future.
For the group of incident ADHD patients, the
Psychosocial Summary Score was significantly higher
compared with the baseline scores after 6 months of
treatment (33.8 versus 41.0, respectively). Further-
more, scores for Role/Social Limitations-Emotional/
Behaviour problems (REB), Behaviour (BE), General
Behaviour (GBE), Mental Health (MH), Parental Im-
pact–Emotional (PE), Parental impact Time (PT) and
Family Activities (FA) were significantly improved at
Table 3 Average number of days lost due to absence from work, reduced
efficiency and indirect costs per year of mothersa of ADHD patients (n = 50)
Type of production loss Number of days Costs (in euros)
Absence from work 17.3 1,691
Reduced Efficiency 5.1 552
Total 22.4 2,243
aThis group consisted of 82% mothers, 17% fathers, and 1% others, referred to
as mothers’
















Fig. 1 Average score on the CHQ-PF 50 at baseline and 6 months of incident
ADHD patients. ADHD = attention-deficit hyperactivity disorder
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six months, see Fig. 1. The improvement of the scores
on the CHQ-PF 50 at 6 months compared to the
baseline measurement was entirely due to the higher
scores of the incident ADHD patients.
As is apparent from the literature, comorbidity has
an additional effect on the quality of life in children
with ADHD [11]. The Psychosocial Summary Score
was lower for the ADHD patients with psychiatric
comorbidity compared to the group of patients with
ADHD only, namely 31.7 and 40.8 respectively. Dif-
ferences were due to significantly worse scores in the
ADHD patient group with comorbid psychiatric dis-
orders on emotional or behavioural problems (REB),
emotional behaviour (BE) and general behaviour
(GBE) and self esteem (SE), compared to the ADHD
patients with no psychiatric comorbidity. We also
found significantly lower scores on the parents’ time
(PT) for this group.
Conclusion
The purpose of this study was to estimate the health
care utilisation, direct medical costs and quality of
life of ADHD patients. To this end, we compared the
overall direct medical costs and quality of life score
with a non-matched group of children with behav-
iour problems and with a group of children with no
behaviour problems (screen negatives). Additionally,
we assessed the health care utilisation and direct
medical costs of the mothers and their indirect costs
due to production losses at work. The response rate
was high (92%), as was the percentage of boys in the
group of ADHD patients (80%). ADHD seems to
impair school performance, as 15% of the ADHD
patients attended special education. The annual di-
rect medical costs of the ADHD patients were esti-
mated at e2040. These costs were seven to eleven
times higher than the direct medical costs of chil-
dren with behaviour problems and of the children
with no behaviour problems, respectively. Psychiat-
ric hospital days and ambulatory mental health care
accounted for over half of the costs. Medication
accounted for 13% of the costs. However, direct
medical costs were highly skewed due to one patient
with a long term hospital admission. Leaving out
this patient the direct medical costs of the ADHD
patients were on average e1173. ADHD patients with
psychiatric comorbidity had higher health care costs
than the ADHD patients with no psychiatric com-
orbidity.
The mean annual direct costs of the mothers of the
ADHD patients were e728. The total indirect costs
due to absence from work and reduced efficiency at
work were e2243. Furthermore, mothers of ADHD
patients had higher impediment scores associated
with a worse performance in paid and household
activities. Direct medical costs and indirect costs for
the mothers of ADHD patients were substantially
higher than for the mothers of the other two groups.
Comorbidity of the child seemed not to influence the
costs of the mother.
The quality of life of the ADHD patients was
significantly worse in the psychosocial domain.
However, ADHD appeared not to have an impact on
the physical domain. Furthermore, ADHD had a
negative impact on the parental time and family
activities.
Table 4 Mean scores on the sub dimensions and the summary scores of the CHQ-PF50 for ADHD patients, children with behaviour problems and children with no
behaviour problems at baseline (higher scores indicates better functioning)
ADHD patients Behaviour problems No behaviour problems
Global Health (GGH) 75.5 79.9 82.3
Physical Functioning (PF) 97.2 96.8 96.2
Role/Social Limitations-Emotional/Behavioural (REB) 76.9* 95.7 94.8
Role/Social Limitations-Physical (RP) 93.3 95.4 98.2
Bodily Pain/Discomfort (BP) 82.5 84 86.7
Behavior (BE) 55.1* 79.7 77.4
Global Behavior Item (GBE) 47.2* 71.8 72.3
Mental Health (MH) 63.5* 79.3 81.9
Self Esteem (SE) 66.0* 78.7 80.4
General Health Perceptions (GH) 79.8 83.4 82.4
Parental Impact-Emotional (PE) 63.4* 87.1 85.9
Parental Impact-Time (PT) 78.3* 96.6 92.8
Family Activities (FA) 64.8* 92.1 87.1
Family Cohesion (FC) 57.6* 71.4 73.8
Physical Summary Score (PhS) 57.5 55.6 55.9
Psychosocial Summary Score (PsS) 38.9* 53.3 52.9
*Significantly different
ADHD = attention-deficit hyperactivity disorder
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Discussion
This is the first cost-of-illness study of ADHD con-
ducted in the Netherlands. In line with similar studies
carried out elsewhere, our study showed that the di-
rect medical costs of ADHD patients were relatively
high. Additionally, our study indicated that ADHD
appears to be accompanied by higher (mental) health
care costs for the mothers of ADHD patients and by
increased indirect costs for this group. This would
seem to concur with the presented relative negative
scores on parental time and family activities on the
CHQ-PF50. HQoL assessment consistently showed a
considerable impairment in the psychological and
social functioning of the children suffering from
ADHD.
The group of children with a high score on a
screenings list for behaviour problems were, by con-
trast, not found to have increased direct medical costs
and worse HRQoL. Our study showed that the per-
centage of mothers with a paid job was higher in the
group of ADHD patients. There was no difference in
mean age and marital status between the groups
which may have explained the variance in work status
of the mothers. Further research on this subject is
needed. Our study had several limitations. Our data
pertained to only a small group of ADHD patients,
who were being treated by a paediatrician. This group
may not be considered to be representative of ADHD
patients in the Netherlands. The ADHD patients were
identified on the bases of a dependent variable; in
treatment for ADHD by a paediatrician. This may
introduce an upward bias to the costs. According to
the paediatrician, this group of ADHD patients should
be regarded as a group of patients with moderate
ADHD. Hence, mild and severe ADHD patients were
probably underrepresented in this sample. However,
unfortunately we did not have data on severity. Fur-
thermore, the small sample limits the external valid-
ity. The number of ADHD patients with psychiatric
comorbidity was small compared to other studies [7].
The reason for this could be twofold. Firstly, the
paediatrician may not have been consistent in
recording comorbidity. Secondly, the ADHD patients
who were treated by a paediatrician may well con-
stitute a group with less severe ADHD. Moreover, due
to the study design, we were unable to match the two
other study groups on age and sex. Hence, the com-
parison of the results is limited; it only offered some
indications of differences between ADHD patients
and two other non-matched groups of children.
In the group of children with behaviour problems,
the number of patients with ADHD according to the
criteria of the DSM-IV was too small to explore
meaningful subgroup analyses.
Compared to a recent Cost-of-illness study for
Belgium our direct medical cost estimate was rela-
tively high. This may be partly due to the variance in
patient selection, the parents were members of the
Flemish-speaking ADHD society [4] and may not be
all under treatment for ADHD during the study.
Furthermore, the costs of hospitalisation and mental
health care in our study were relatively high. In our
study the costs of hospitalisation were high due to an
admission of 84 days to a psychiatric hospital of one
patient.
Another limitation of the study was that questions
regarding use of medical resources and productivity
losses were not specific to ADHD, but referred to
health problems in general. Hence, the cost estimate
in this study referred to the costs of direct medical
costs of patients suffering from ADHD and not to the
costs of ADHD for these patients. Due to the symp-
toms of ADHD, parents of ADHD patients cannot
easily distinguish between problems related to ADHD
itself and other mental and psychosomatic health
problems. On the one hand, this may lead to the costs
of ADHD being overestimated. On the other hand, our
study failed to include severely ill ADHD patients,
leading to an underestimate of the mean costs.
The annual costs were based on two measurement
points with a recall period of three months. Studies
have indicated that the accuracy of data on health care
utilisation decreases with long recall periods [9, 10,
17]. We assumed that the three months were repre-
sentative for the entire six-month period.
In case of missing data at the second measurement
moment (at six months) we applied a naı¨ve method to
deal with missing observations compared to, for in-
stance, multiple imputation [20]. However, the influ-
ence of the imputing method was limited as the
number of missings was small.
The number of children with ADHD attending
special education was significantly higher. We did not
value these costs to society. However, these costs are
probably relatively high compared to other costs
components.
We collected no data on the cost of crime. Inter-
national studies have shown that ADHD patients are
at an increased risk for criminal activities [18].
However, these costs were expected to be low in the
age group included in our study.
The scores of the children with no behaviour
problems on the CHQ-PF50 were comparable to the
scores obtained in a group of Dutch school-aged
children, indicating the comparison group may be
used as a reference group [23].
In our study, the group of ADHD patients visiting
the paediatrician for the first time at baseline showed
better HQoL after six months, suggesting that the
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treatment of ADHD was effective. However, this result
does not assess the marginal cost-effectiveness of
individual treatments of ADHD.
A cost-of illness estimate cannot be interpreted as
the savings to be achieved with new successful med-
ical interventions. However, the results of a cost-of
illness study may provide helpful information when
designing a cost-effectiveness study. For instance, the
estimates of the direct medical costs in certain patient
groups may be useful in estimating the reduction of
costs as a consequence of a successful intervention.
Overall, the societal costs of patients suffering from
ADHD were high. This particularly applied with re-
spect to mental health care costs. The assessment of
health status showed considerable impairment in the
psychological and social functioning of ADHD pa-
tients. Furthermore, ADHD patients seem to place an
economic burden on the family. Mothers of ADHD
patients appear to be confronted with higher direct
costs for mental health care, higher indirect costs and
more impairment in performing paid and unpaid
jobs.
j Acknowledgement The study was financed by an unrestricted
grant of Eli Lilly Netherlands BV.
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